Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidates

Journal of Virology

Volumn 80, Issue 10, 2006, Pages 4949-4961

  VanCott, John L ^a   Prada, Anne E ^a   McNeal, Monica M ^a   Stone, Susan C ^a   Basu, Mitali ^a   Huffer Jr , Bert ^a   Smiley, Kristi L ^a   Shao, Mingyuan ^a   Bean, Judy A ^a   Clements, John D ^b   Choi, Anthony H C ^a   Ward, Richard L ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b TULANE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIBODY; GAMMA INTERFERON; HEAT LABILE TOXIN; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; NEUTRALIZING ANTIBODY; PROTEIN VP6; ROTAVIRUS VACCINE; SIMIAN ROTAVIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; MEMORY T LYMPHOCYTE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; ROTAVIRUS; SPLEEN CELL; TH1 CELL; TH2 CELL; VIRUS INFECTION; VIRUS SHEDDING;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ANIMALS; ANIMALS, NEWBORN; ANTIGENS, VIRAL; BACTERIAL TOXINS; CAPSID PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; ENTEROTOXINS; ESCHERICHIA COLI PROTEINS; FEMALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; RATS; ROTAVIRUS; ROTAVIRUS VACCINES; VACCINES, ATTENUATED; VACCINES, INACTIVATED;

ANIMALIA; ESCHERICHIA COLI; MURINE ROTAVIRUS; RHESUS ROTAVIRUS; ROTAVIRUS; ROTAVIRUS B; SIMIAN ROTAVIRUS;

EID: 33646446731     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.80.10.4949-4961.2006     Document Type: Article

References (75)

1. H2 function. Int. Rev. Immunol. 19:195-219.
2. Adkins, B., C. Leclerc, and S. Marshall-Clarke. 2004. Neonatal adaptive immunity comes of age. Nat. Rev. 4:553-564.
3. Adkins, B., T. Williamson, P. Guevara, and Y. Bu. 2003. Murine neonatal lymphocytes show rapid early cell cycle entry and cell division. J. Immunol. 170:4548-4556.
4. Bass, D. M. 1997. Interferon gamma and interleukin 1, but not interferon alpha, inhibit rotavirus entry into human intestinal cell lines. Gastroenterology 113:81-89.
5. Bernstein, D. I., and R. L. Ward. 2004. Rotaviruses, p. 2110-2111. In R. D. Feigin, J. D. Cherry, G. J. Demmler, and S. L. Kaplan (ed.), Textbook of pediatric infectious diseases, 5th ed. Saunders, Philadelphia, Pa.
6. Bhan, M. K., J. F. Lew, S. Sazawal, B. K. Das, J. R. Gentsch, and R. I. Glass. 1993. Protection conferred by neonatal rotavirus infection against subsequent rotavirus diarrhea. J. Infect. Dis. 168:282-287.
7. Bienenstock, J., and R. L. Clancy. 2005. Bronchus-associated lymphoid tissues, p. 375-384. In J. Mestecky, M. E. Lamm, W. Strober, J. Bienenstock, J. R. McGhee, and L. Meyer (ed.), Mucosal immunology, 3rd ed. Elsevier Academic Press, Burlington, Mass.
8. Bishop, R., G. Barnes, F. Cipriani, and J. S. Lund. 1983. Clinical immunity after neonatal rotavirus infection: a prospective longitudinal study in young children. N. Engl. J. Med. 309:72-76.
9. Burns, J. W., M. Siadat-Pajouh, A. A. Krishnaney, and H. B. Greenberg. 1996. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 272:104-107.
10. Cebra, J. J. 1999. Influences of microbiota on intestinal immune system development. Am. J. Clin. Nutr. 69:1046S-1051S.
11. Chiba, S., T. Yokoyama, S. Nakata, Y. Morita, T. Drasawa, K. Taniguchi, S. Urasawa, and T. Nakao. 1986. Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies. Lancet i:417-421.
12. Choi, A. H., M. Basu, M. M. McNeal, J. A. Bean, J. D. Clements, and R. L. Ward. 2004. Intranasal administration of an Escherichia coli-expressed codon-optimized rotavirus VP6 protein induces protection in mice. Protein Expr. Purif. 38:205-216.
13. Choi, A. H., M. Basu, M. M. McNeal, J. D. Clements, and R. L. Ward. 1999. Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein. J. Virol. 73:7574-7581.
14. Choi, A. H., M. Basu, M. M. McNeal, J. Flint, J. L. VanCott, J. D. Clements, and R. L. Ward. 2000. Functional mapping of protective domains and epitopes in the rotavirus VP6 protein. J. Virol. 74:11574-11580.
15. Choi, A. H., D. R. Knowlton, M. M. McNeal, and R. L. Ward. 1997. Particle bombardment-mediated DNA vaccination with rotavirus VP6 induces high levels of serum rotavirus IgG but fails to protect mice against challenge. Virology 232:129-138.
16. Choi, A. H., M. M. McNeal, M. Basu, J. A. Flint, S. C. Stone, J. D. Clements, J. A. Bean, S. A. Poe, J. L. VanCott, and R. L. Ward. 2002. Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses. Vaccine 20:3310-3321.
17. + T cell-mediated control of a γ-herpesvirus in B cell-deficient mice is mediated by IFN-γ. Proc. Natl. Acad. Sci. USA 96:5135-5140.
18. Clemens, J. D., R. L. Ward, D. A. Sack, M. R. Rao, D. R. Knowlton, F. van Loon, S. Huda, M. McNeal, F. Ahmed, and G. M. Schiff. 1992. Seroepidemiologic evaluation of antibodies to rotavirus as correlates of the risk of clinically significant rotavirus diarrhea in rural Bangladesh. J. Infect. Dis. 165:161-165.
19. Coulson, B. S., K. Grimwood, I. L. Hudson, G. L. Barnes, and R. F. Bishop. 1992. Role of coproantibody in clinical protection of children during reinfection with rotavirus. J. Clin. Microbiol. 30:1678-1684.
20. De Vos, B., T. Vesikari, A. C. Linhares, B. Salinas, I. Perez-Schael, G. M. Ruiz-Palacios, M. de L. Guerrero, K. B. Phua, A. Delem, and K. Hardt. 2004. A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis. Pediatr. Infect. Dis. J. 23:S179-S182.
21. Dickinson, B. L., and J. D. Clements. 1995. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect. Immun. 63:1617-1623.
22. Estes, M. K. 2001. Rotaviruses and their replication, p. 1747-1785. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, Pa.
23. Feng, N., J. W. Burns, L. Bracy, and H. B. Greenberg. 1994. Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus. J. Virol. 68:7766-7773.
24. Feng, N., J. A. Lawton, J. Gilbert, N. Kuklin, P. Vo, B. V. V. Prasad, and H. B. Greenberg. 2002. Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb. J. Clin. Investig. 109:1203-1213.
25. Feng, N., P. T. Vo, D. Chung, Y. Hoshino, and H. B. Greenberg. 1997. Heterotypic protection following oral immunization with live heterologous rotaviruses in the mouse model. J. Infect. Dis. 175:330-341.
26. Fessiez, F., O. Djossou, P. Chomarat, L. Flores-Romo, S. Ait-Yahia, C. Maat, J. J. Pin, P. Garrone, E. Garcia, S. Saeland, D. Blanchard, C. Gaillard, B. Das Mahapatra, E. Rouvier, P. Golstein, J. Banchereau, and S. Lebecque. 1996. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183:2593-2603.
27. Franco, M. A., and H. B. Greenberg. 1995. Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice. J. Virol. 69:7800-7806.
28. Freytag, L. C., and J. D. Clements. 2005. Mucosal adjuvants. Vaccine 23:1804-1813.
29. Garcia, A. M., S. A. Fadel, S. Cao, and M. Sarzotti. 2000. T cell immunity in neonates. Immunol. Res. 22:177-190.
30. Happel, K. I., P. J. Dubin, M. Zheng, N. Ghilardi, C. Lockhart, L. J. Quinten, A. R. Odden, J. E. Shellito, G. J. Bagby, S. Nelson, and J. Kolls. 2005. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumonias. J. Exp. Med. 202:761-769.
31. Happel, K. I., E. A. Lockhart, C. M. Mason, E. Porretta, E. Keoshkerian, A. R. Odden, S. Nelson, and A. J. Ramsay. 2005. Pulmonary interleukin-23 gene delivery increases local T-cell immunity and controls growth of Mycobacterium tuberculosis in the lungs. Infect. Immun. 73:5782-5788.
32. + T cells in controlling retrovirus replication and spread in persistently infected mice. J. Virol. 72:6559-6564.
33. Hendrickson, B. A., L. Rindisbacher, B. Corthesy, D. Kendall, D. A. Waltz, M. R. Neutra, and J. G. Seidman. 1996. Lack of association of secretory component with IgA in J chain-deficient mice. J. lmmunol. 157:750-754.
34. + T cells that persist in the lungs. J. Exp. Med. 193:981-986.
35. Kapikian, A. Z., Y. Hoshino, and R. M. Chanock. 2001. Rotaviruses, p. 1787-1833. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, Pa.
36. Knowlton, D. R., D. M. Specter, and R. L. Ward. 1991. Development of an improved method for measuring neutralizing antibody to rotavirus. J. Virol. Methods 33:127-134.
37. Kolls, J. K., and A. Linden. 2004. Interleukin-17 family members and inflammation. Immunity 21:467-476.
38. Lambert, P. H., M. Liu, and C. A. Siegrist. 2005. Can successful vaccines teach us how to induce efficient protective immune responses? Nat. Med. 11:S54-S62.
39. Le Campion, A., C. Bourgeois, F. Lambolez, B. Martin, S. Leaument, N. Dautigny, C. Tanchot, C. Penit, and B. Lucas. 2002. Naive T cells proliferate strongly in neonatal mice in response to self-peptide/self-MHC complexes. Proc. Natl. Acad. Sci. USA 99:4538-4543.
40. + T cells. J. Virol. 69:4611-4716.
41. Maison, D. O., M. L. O'Ryan, I. Herrera, L. K. Pickering, and M. K. Estes. 1993. Fecal antibody responses to symptomatic and asymptomatic rotavirus infections. J. Infect. Dis. 167:577-583.
42. + cells in resolution of rotavirus infection and protection against reinfection in mice. Virology 214:387-397.
43. McNeal, M. M., R. L. Broome, and R. L. Ward. 1994. Active immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination. Virology 204:642-650.
44. McNeal, M. M., S. C. Stone, M. Basu, J. A. Bean, J. D. Clements, B. A. Hendrickson, A. H.-C. Choi, and R. L. Ward. 2006. Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgA. Virology. 346:338-347.
45. McNeal, M. M., M. N. Rae, J. A. Bean, and R. L. Ward. 1999. Antibody-dependent and -independent protection following intranasal immunization of mice with rotavirus particles. J. Virol. 73:7565-7573.
46. McNeal, M. M., M. N. Rae, and R. L. Ward. 1997. Evidence that resolution of rotavirus infection in mice is due to both CD8 cells and CD4 cell-dependent antibody. J. Virol. 71:8735-8742.
47. McNeal, M., J. Sheridan, and R. Ward. 1992. Active protection against rotavirus infection of mice following intraperitoneal immunization. Virology 191:150-157.
48. McNeal, M. M., J. L. VanCott, A. H. C. Choi, M. Basu, J. A. Flint, S. C. Stone, J. D. Clements, and R. L. Ward. 2002. CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G). J. Virol. 76:560-568.
49. McNeal, M. M., and R. L. Ward. 1995. Long-term production of rotavirus antibody and protection against reinfection following a single infection of neonatal mice with murine rotavirus. Virology 211:474-480.
50. + T lymphocytes possessing cytolytic activity confer protection in the absence of prophylactic antibodies. J. Virol. 69:4914-4923.
51. Offit, P., and H. F. Clark. 1985. Protection against rotavirus-induced gastroenteritis in a murine model by passively acquired gastrointestinal but not circulating antibodies. J. Virol. 54:58-64.
52. O'Neal, C. M., J. D. Clements, M. K. Estes, and M. E. Conner. 1998. Rotavirus 2/6 virus-like particles administered intranasally with cholera toxin, Escherichia coli heat-labile toxin (LT), and LT-R192G induce protection from rotavirus challenge. J. Virol. 72:3390-3393.
53. O'Neal, C. M., S. E. Crawford, M. K. Estes, and M. E. Conner. 1997. Rotavirus virus-like particles administered mucosally induce protective immunity. J. Virol. 71:8707-8717.
54. Parashar, U. D., E. G. Hummelman, J. S. Bresee, M. A. Miller, and R. I. Glass. 2003. Global illness and deaths caused by rotavirus disease in children. Emerg. Infect. Dis. 9:565-572.
55. Pihlgren, M., C. Tougne, P. Bozzotti, A. Fulurija, M. A. Duchosal, P. H. Lambert, and C. A. Siegrist. 2003. Unresponsiveness to lymphoid-mediated signals at the neonatal follicular dendritic cell precursor level contributes to delayed germinal center induction and limitations of neonatal antibody responses to T-dependent antigens. J. Immunol. 170:2824-2832.
56. + T-cell-mediated antiviral protection of the upper respiratory tract in BALB/c mice following parenteral immunization with a recombinant respiratory syncytial virus G protein fragment. J. Virol. 74:3455-3463.
57. Ruiz-Palacios, G. M., I. Pérez-Schael, F. R. Valázquez, H. Abate, T. Breuer, S. C. Clemens, B. Cheuvart, F. Espinoza, P. Gillard, B. L. Innis, Y. Cervantes, A. C. Linbares, P. López, M. Macías-Parra, E. Orteda-Barría, V. Richardson, D. M. River-Medina, L. Rivera, B. Salinas, N. Pavía-Ruz, J. Salmerón, R. Riittimann, J. Tinoco, P. Rubio, E. Nuñez, M. L. Guerrero, J. P. Yarzábal, S. Damaso, N. Tornieporth, X. Sáez-Llorens, R. F. Vergara, T. Vesikari, A. Bouckenooghe, R. Clemens, B. De Vos, and M. O'Ryan. 2006. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N. Engl. J. Med. 354:11-22.
58. Savage, D. C. 2005. Mucosal microbiota, p. 19-33. In 3. Mestecky, M. E. Lamm, W. Strober, J. Bienenstock, J. R. McGhee, and L. Mayer (ed.), Mucosal immunology, 3rd ed. Elsevier Academic Press, Burlington, Mass.
59. Schaller, J. P., L. J. Saif, C. T. Cordle, E. Candler, Jr., T. R. Winship, and K. L. Smith. 1992. Prevention of human rotavirus-induced diarrhea in gnotobiotic piglets using bovine antibody. J. Infect. Dis. 165:623-630.
60. Schwartz-Cornil, I., Y. Benureau, H. Greenberg, B. A. Hendrickson, and J. Cohen. 2002. Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins. J. Virol. 76:8110-8117.
61. Siegrist, C. A. 2001. Neonatal and early life vaccinology. Vaccine 19:3331-3346.
62. Snodgrass, D., K. Fahey, P. W. Wells, I. Campbell, and A. Whitelaw. 1980. Passive immunity in calf rotavirus infections: maternal vaccination increases and prolongs immunoglobulin Gl antibody secretion in milk. Infect. Immun. 28:344-349.
63. Umesaki, Y., and H. Setoyama. 2000. Structure of the intestinal flora responsible for development of the gut immune system in a rodent model. Microbes Infect. 2:1343-1351.
64. Van Kooten, C., J. G. Boonstra, M. E. Paape, F. Fossiez, J. Banchereau, S. Lebecque, J. A. Bruijn, J. W. De Fijter, L. A. Van Es, and M. R. Daha. 1998. Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection. J. Am. Soc. Nephrol. 9:1526-1534.
65. Velazquez, F. R., D. O. Matson, M. L. Guerrero, J. Shults, J. J. Calva, A. L. Morrow, R. I. Glass, L. K. Pickering, and G. M. Ruiz-Palacios. 2000. Serum antibody as a marker of protection against natural rotavirus infection and disease. J. Infect. Dis. 182:1602-1609.
66. Vesikari, T., D. O. Matson, P. Dennehy, P. Van Damme, M. Santosham, Z. Rodriguez, M. J. Dallas, J. F. Hey se, M. G. Goveia, S. B. Black, H. R. Shinefleld, C. D. C. Christie, S. Ylitalo, R. F. Itzler, M. L. Coia, M. T. Onorato, B. A. Adeyi, G. S. Marshall, L. Golhefors, D. Campens, A. Karvonen, J. P. Walls, K. L. O'Brien, M. J. DiNubile, H. F. Clark, J. W. Boslego, P. A. Offit, and P. M. Heaton. 2006. Safety and efficacy of a pentavalent human bovine (WC3) reassortant rotavirus vaccine. N. Engl. J. Med. 354:23-33.
67. Ward, L. A., L. Yuan, B. I. Rosen, T. L. To, and L. J. Saif. 1996. Development of mucosal and systemic lymphoproliferative responses and protective immunity to human group A rotaviruses in a gnotobiotic pig model. Clin. Diagn. Lab. Immunol. 3:342-350.
68. Ward, R. L., D. I. Bernstein, R. Shukla, E. C. Young, J. R. Sherwood, M. M. McNeal, M. C. Walker, and G. M. Schiff. 1989. Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus. J. Infect. Dis. 159:79-88.
69. Ward, R. L., H. F. Clark, P. A. Offit, and R. I. Glass. 2004. Live vaccine strategies to prevent rotavirus disease, p. 607-620. In M. M. Levine, J. B. Kaper, R. Rappuoli, M. Liu, and M. F. Good (ed.), New generation vaccines, 3rd ed. Marcel Dekker, New York, N.Y.
70. Ward, R. L., M. M. McNeal, and J. F. Sheridan. 1990. Development of an adult mouse model for studies on protection against rotavirus. J. Virol. 64:5070-5075.
71. Ward, R. L., M. M. McNeal, and J. F. Sheridan. 1992. Evidence that active protection following oral immunization of mice with live rotavirus is not dependent on neutralizing antibody. Virology 188:57-66.
72. Witowski, J., K. Pawlaczyk, A. Breborowicz, A. Scheuren, M. Kuzlan-Pawlaczyk, J. Wisniewska, A. Polubinska, H. Friess, G. M. Gahl, U. Frei, and A. Jorres. 2000. IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J. Immunol. 165:5814-5821.
73. Youngman, K. R., N. H. Lazarus, and E. C. Butcher. 2005. Lymphocyte homing: chemokines and adhesion molecules in T cell and IgA plasma cell localization in the mucosal immune system, p. 375-384. In J. Mestecky, M. E. Lamm, W. Strober, J. Bienenstock, J. R. McGhee, and L. Meyer (ed.), Mucosal immunology, 3rd ed. Elsevier Academic Press, Burlington, Mass.
74. Yuan, L., A. Geyer, D. C. Hodgins, Z. Fan, Y. Qian, K.-O. Chang, S. E. Crawford, V. Parreño, L. A. Ward, M. K. Estes, M. E. Conner, and L. J. Saif. 2000. Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs. J. Virol. 74:8843-8853.
75. Yuan, L., L. A. Ward, B. I. Rosen, T. L. To, and L. J. Saif. 1996. Systemic and intestinal antibody-secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease. J. Virol. 70:3075-3083.